Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 743-751

  Nickenig, Georg ^a   Murphy, T J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; MESSENGER RNA; RNA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; RNA ANALYSIS; RNA DEGRADATION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; AUTORADIOGRAPHY; CELLS, CULTURED; CYCLOHEXIMIDE; DRUG STABILITY; MUSCLE, SMOOTH, VASCULAR; POLYRIBOSOMES; RATS; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; RNA, RIBOSOMAL; RNA-BINDING PROTEINS; STIMULATION, CHEMICAL; SUBCELLULAR FRACTIONS;

EID: 0029959121     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Griendling, K. K., T. J. Murphy, and R. W. Alexander. Molecular biology of the renin-angiotensin system. Circulation 87:1816-1828 (1993).
2. Hausdorff, W. P., M. G. Caron, and R. J. Lefkowitz. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:2881-2889 (1990).
3. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-688 (1991).
4. Hadcock, J. R., H. Y. Wang, and C. C. Malbon. Agonist-induced destabilization of β-adrenergic receptor mRNA: attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors. J. Biol. Chem. 264: 19928-19933 (1989).
5. Hadcock, J. R., and C. C. Malbon. Down-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc. Natl. Acad. Sci. USA 85:5021-5025 (1988).
6. Bouscarel, B., P. B. Wilson, P. F. Blackmore, C. F. Lynch, and J. H. Exton. Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes. J. Biol. Chem. 263:14920-14924 (1988).
7. Tufro-McReddie, A., R. L. Chevalier, A. D. Everett, and R. A. Gomez. Decreased perfusion pressure modulates renin and AngII type 1 receptor gene expression in the rat kidney. Am. J. Physiol. 264:R696-R702 (1993).
8. Pucell, A. G., F. M. Bumpus, and A. Husain. Regulation of angiotensin II receptors in cultured rat ovarian granulosa cells by follicle-stimulating hormone and angiotensin II. J. Biol. Chem. 263:11954-11961 (1988).
9. Nickenig, G., and T. J. Murphy. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol. Pharmacol. 46:653-659 (1994).
10. Chen, X., J. Nishimura, J. Hasna, S. Kobayashi, T. Shikasho, and H. Kanaide. Protein kinase C and protein kinase A regulate the expression of angiotensin II receptor mRNA in smooth muscle cells. Eur. J. Pharmacol. 267:175-183 (1994).
11. 1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol. Pharmacol. 48:601-609 (1995).
12. Atwater, J. A., R. Wisdom, and I. M. Verma. Regulated mRNA stability. Annu. Rev. Genet. 24:519-541 (1990).
13. Sachs, A. Messenger RNA degradation in eukaryotes. Cell 74:413-421 (1993).
14. Gunther, S., R. W. Alexander, W. S. Atkinson, and M. A. Gimbrone. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J. Cell Biol. 92:289-298 (1982).
15. Ross, J., G. Kobs, G. Brewer, and S. W. Peltz. Properties of the exonuclease activity that degrades H4 histone mRNA. J. Biol. Chem. 262:9374-9381 (1987).
16. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489 (1983).
17. Murphy, T. J., R. W. Alexander, K. K. Griendling, M. S. Runge, and K. E. Bernstein. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond.) 351:233-236 (1991).
18. Chen, C. Y. A., Y. You, and A. B. Shyu. Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol. Cell. Biol. 12:5748-5757 (1992).
19. Brewer, G. An A+U element RNA binding protein regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11:2460-2466 (1991).
20. Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. DeMaria, D. Crater, K. DeHaven, L. Long, and G. Brewer. Purification, characterization and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652-7665 (1993).
21. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267:6302-6309 (1992).
22. You, Y., C. Y. A. Chen, and A. B. Shyu. U-rich sequence binding proteins interacting with a 2-nucleotide U-rich sequence in the 3′ untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol. Cell. Biol. 12:2931-2940 (1992).
23. Bickel, M., Y. Iwai, H. Pluznik, and R. B. Cohen. Binding of sequencespecific proteins to the adenosine- plus uridine-rich sequences of the murine granulocyte/macrophage colony stimulating factor mRNA. Proc. Natl. Acad. Sci USA 89:10001-10005 (1992).
24. Takeuchi, K., R. W. Alexander, Y. Nakamura, T. Tsujino, and T. J. Murphy. Molecular structure and transcriptional function of the rat vascular AT1a angiotensin receptor gene. Circ. Res. 73:612-621 (1993).
25. r 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs. J. Biol. Chem. 267: 24103-24108 (1992).
26. r. 35,000 β-adrenergic receptor mRNA-binding protein induced by agonists requires both an AUUA pentamer and U-rich domains for RNA recognition. J. Biol. Chem. 268:25769-25775 (1993).
27. Tholanikunnel, B. G., J. G. Granneman, and C. C. Malbon. The M(r) 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J. Biol. Chem. 270:12787-12793 (1995).
28. Jackson, C. L., and S. M. Schwartz. Pharmacology of smooth muscle cell replication. Hypertension (Dallas) 20:713-736 (1992).
29. Sartore, S., M. Scatena, A. Chiavegator, E. Faggin, L. Giuriato, and P. Pauletto. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J. Vase. Res. 31:61-81 (1994).